Global prevalence of cerebral palsy: A systematic analysis

Sarah McIntyre1, Shona Goldsmith1, Annabel Webb1

  • 1Cerebral Palsy Alliance Research Institute, Specialty of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Insights

Cerebral palsy (CP) birth prevalence is decreasing in high-income countries, now at 1.6 per 1000 live births. However, prevalence in low- and middle-income countries remains markedly higher, with trends yet to be measured.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • Cerebral palsy (CP) is a group of disorders affecting movement and posture, with varying prevalence globally.
  • Understanding CP trends is crucial for public health planning and resource allocation.

Purpose of the Study:

  • To determine current global and regional prevalence estimates of cerebral palsy (CP).
  • To analyze trends in CP prevalence, distinguishing between pre-/perinatal, postnatal, neonatal, and overall cases.

Main Methods:

  • Systematic analysis of data from 41 regions across 27 countries, utilizing CP registers, surveillance systems, and population-based studies (birth year 1995 onwards).
  • Quality and risk of bias assessments were performed. Meta-analyses were conducted for prevalence estimates from birth year 2010 onwards.

Main Results:

  • Pre-/perinatal CP birth prevalence significantly declined in 11 out of 14 European and Australian regions.
  • Current overall CP birth prevalence in high-income countries (HICs) is 1.6 per 1000 live births.
  • Data from low- and middle-income countries (LMICs) indicate markedly higher birth prevalence, with pre-/perinatal CP as high as 3.4 per 1000 live births.

Conclusions:

  • CP birth prevalence is declining in HICs, but remains significantly higher in LMICs.
  • Active surveillance and population-based data are essential for informing policy and assessing the impact of interventions.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
753
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
686
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
240